|
Aug 6
|
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
|
|
Jul 27
|
Galapagos Second Quarter 2025 Earnings: Misses Expectations
|
|
Jul 23
|
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
|
|
Jul 23
|
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors
|
|
Jul 23
|
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
|
|
Jun 18
|
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
|
|
Jun 17
|
Owning 37% shares,institutional owners seem interested in Galapagos NV (AMS:GLPG),
|
|
May 27
|
Galapagos Creates New Subscription Right Plan
|
|
Apr 15
|
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
|
|
Apr 1
|
Biotech stocks slide as Marks resignation seen being negative for sector
|
|
Feb 14
|
Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience
|
|
Feb 12
|
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
|
|
Feb 12
|
Galapagos NV (GLPG): A Cheap Biotech Stock to Invest In Now
|
|
Oct 7
|
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
|
|
May 16
|
Galapagos creates new subscription right plans
|
|
May 15
|
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
|
|
Apr 4
|
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
|
|
Apr 3
|
After Plunging -7.94% in 4 Weeks, Here's Why the Trend Might Reverse for Galapagos (GLPG)
|
|
Feb 24
|
Galapagos NV (NASDAQ:GLPG) Q4 2023 Earnings Call Transcript
|
|
Feb 22
|
Galapagos announces full year 2023 results and outlook for 2024
|